Cleocin Phosphate Injection, Solution
Product Images NDC 0009-3051

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cleocin Phosphate (NDC 0009-3051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cleocin 01)

Chemical structure of clindamycin phosphate, the active ingredient in Cleocin Phosphate injection, solution 150 mg/mL by Pharmacia & Upjohn Company LLC. The image depicts the molecular arrangement including a phosphate group and various connected rings.*

FDA Label Image

Logo (Cleocin 02)

FDA Label Image

Principal Display Panel (2 mL Vial Label)

Label for Cleocin Phosphate clindamycin injection, USP 2 mL vial, concentration 150 mg/mL, providing 300 mg per 2 mL dose. Indicates use for intramuscular or intravenous injection. Distributed by Pharmacia & Upjohn Company LLC. Storage instructions specify controlled room temperature (20° to 25°C). Single dose container.*

FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Carton packaging label for Cleocin Phosphate clindamycin injection, USP, 300 mg/2 mL (150 mg/mL) injection solution. The label states it contains 25 single-dose 2 mL vials for intramuscular or intravenous use. Distributed by Pharmacia & Upjohn Co, Pfizer division. The label includes storage instructions, dosage note, and a warning about dilution if administered intravenously.*

FDA Label Image

Principal Display Panel (4 mL Vial Label)

Label for Cleocin Phosphate clindamycin injection, USP, 600 mg/4 mL (150 mg/mL) in a 4 mL vial. The label states it is for intramuscular or intravenous use, is Rx only, and distributed by Pharmacia & Upjohn Company LLC. Storage instructions specify controlled room temperature 20° to 25°C (68° to 77°F) with no refrigeration. The label includes a lot/expiration box and a barcode.*

FDA Label Image

Principal Display Panel (4 mL Vial Carton)

The packaging label for Cleocin Phosphate injection, USP, clindamycin phosphate, 600 mg/4 mL (150 mg/mL) solution for intramuscular or intravenous use. The label indicates a package of 25 single-dose 4 mL vials. Distributed by Pharmacia & Upjohn Company LLC, the label includes storage instructions, dosage, usage warnings, barcodes, and the Novaplus trademark.*

FDA Label Image

Principal Display Panel (6 mL Vial Label)

Label for Cleocin Phosphate (clindamycin phosphate) injection, USP 150 mg/mL solution in a 6 mL vial. The label indicates it is for intramuscular or intravenous use, containing 900 mg per 6 mL. It is distributed by Pharmacia & Upjohn Company LLC. Storage instructions specify controlled room temperature (20° to 25°C) and not to refrigerate. The label notes single dose container and dosage information reference.*

FDA Label Image

Principal Display Panel (6 mL Vial Carton)

The packaging label for Cleocin Phosphate clindamycin injection, USP, 900 mg/6 mL (150 mg/mL) solution for intramuscular or intravenous use. The carton contains 25 single-dose 6 mL vials. Distributed by Pharmacia & Upjohn Company LLC, it features a green and yellow color scheme with the Novaplus logo and storage instructions at controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.